Investigating how a specific protein affects gene expression in heart cells.
Post-Transcriptional Regulation of Gene Expression by Ribosome-Binding Protein 1
This study is looking at how a protein called RRBP1 helps control the way heart muscle cells make important proteins, especially after heart injuries, to find new ways to help the heart heal and work better.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Arizona NIH-funded |
| Lab location | 1 site (Tucson, United States) |
| Project ID | NIH-11087711 on NIH RePORTER |
What this research studies
This research focuses on understanding the role of ribosome-binding protein 1 (RRBP1) in regulating gene expression at the post-transcriptional level in cardiac myocytes, which are the muscle cells of the heart. The study aims to explore how RRBP1 interacts with RNA in the endoplasmic reticulum (ER) to influence the production of secretory proteins that are crucial for heart function. By examining the effects of RRBP1 on cardiac health, particularly after events like myocardial infarction, the research seeks to uncover new mechanisms that could improve heart recovery and function. Patients may benefit from insights gained about how to enhance cardiac repair processes through targeted protein regulation.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals with cardiac diseases or those who have experienced myocardial infarction.
Not a fit: Patients with non-cardiac conditions or those without any history of heart disease may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapeutic strategies for improving heart function and recovery after cardiac injuries.
How similar studies have performed: While the specific focus on RRBP1 is novel, previous studies have shown success in understanding post-transcriptional regulation in other contexts, suggesting potential for impactful findings.
Where this research is happening
Tucson, United States
- University of Arizona — Tucson, United States (Active)
Researchers
- Principal investigator: Doroudgar, Shirin — University of Arizona
- Study coordinator: Doroudgar, Shirin
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.